$16.20
00.00%
At close: Jun 27, 4:11 PM EDT
$16.20
00.00%
After Hours: 4:11 PM EDT
15 minutes delayed
Innoviva
INVANASDAQ
Innoviva (NASDAQ:INVA) Stock, Analyst Ratings, Price Targets, Predictions
Innoviva Inc has a consensus price target of $11.38, established from looking at the 15 latest analyst ratings. The last 3 analyst ratings were released from EF Hutton, EF Hutton, and Goldman Sachs on May 10, 2023, April 20, 2023, and March 3, 2023. With an average price target of $19.33 between EF Hutton, EF Hutton, and Goldman Sachs, there's an implied 19.34% upside for Innoviva Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Cantor Fitzgerald
EF Hutton
Goldman Sachs
Morgan Stanley
1calculated from analyst ratings
Analyst Ratings for Innoviva
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 06/20/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen | — | Reiterates | → Overweight | Get Alert |
| 06/18/2024 | Buy Now | — | Cantor Fitzgerald | Louise Chen | — | Initiates | → Overweight | Get Alert |
| 05/10/2023 | Buy Now | 38.89% | EF Hutton | Constantine Davides | → $22.5 | Reiterates | → Buy | Get Alert |
| 04/20/2023 | Buy Now | 38.89% | EF Hutton | Constantine Davides | → $22.5 | Reiterates | → Buy | Get Alert |
| 03/03/2023 | Buy Now | -19.75% | Goldman Sachs | Chris Shibutani | $15 → $13 | Maintains | Neutral | Get Alert |
| 03/03/2023 | Buy Now | -38.27% | Morgan Stanley | Matthew Harrison | $13 → $10 | Maintains | Underweight | Get Alert |
| 03/03/2023 | Buy Now | 38.89% | EF Hutton | Constantine Davides | → $22.5 | Reiterates | → Buy | Get Alert |
| 01/24/2023 | Buy Now | -19.75% | Morgan Stanley | Matthew Harrison | $14 → $13 | Maintains | Underweight | Get Alert |
| 10/13/2022 | Buy Now | -13.58% | Morgan Stanley | Matthew Harrison | $13 → $14 | Maintains | Underweight | Get Alert |
| 08/08/2022 | Buy Now | -19.75% | Morgan Stanley | Matthew Harrison | $12 → $13 | Maintains | Underweight | Get Alert |
| 07/20/2022 | Buy Now | -1.23% | Goldman Sachs | Chris Shibutani | → $16 | Initiates | → Neutral | Get Alert |
| 07/15/2022 | Buy Now | -25.93% | Morgan Stanley | Matthew Harrison | $13 → $12 | Maintains | Underweight | Get Alert |
| 04/12/2022 | Buy Now | -19.75% | Morgan Stanley | Matthew Harrison | $12 → $13 | Maintains | Underweight | Get Alert |
| 02/23/2022 | Buy Now | -25.93% | Morgan Stanley | Matthew Harrison | $10 → $12 | Maintains | Underweight | Get Alert |
| 02/11/2022 | Buy Now | 72.84% | EF Hutton | Constantine Davides | → $28 | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Innoviva (INVA) stock?
The latest price target for Innoviva (NASDAQ:INVA) was reported by Cantor Fitzgerald on June 20, 2024. The analyst firm set a price target for $0.00 expecting INVA to fall to within 12 months (a possible -100.00% downside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Innoviva (INVA)?
The latest analyst rating for Innoviva (NASDAQ:INVA) was provided by Cantor Fitzgerald, and Innoviva reiterated their overweight rating.
When was the last upgrade for Innoviva (INVA)?
There is no last upgrade for Innoviva
When was the last downgrade for Innoviva (INVA)?
There is no last downgrade for Innoviva.
When is the next analyst rating going to be posted or updated for Innoviva (INVA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Innoviva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Innoviva was filed on June 20, 2024 so you should expect the next rating to be made available sometime around June 20, 2025.
Is the Analyst Rating Innoviva (INVA) correct?
While ratings are subjective and will change, the latest Innoviva (INVA) rating was a reiterated with a price target of $0.00 to $0.00. The current price Innoviva (INVA) is trading at is $16.20, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.